TW200716107A - Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester - Google Patents
Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl esterInfo
- Publication number
- TW200716107A TW200716107A TW095119674A TW95119674A TW200716107A TW 200716107 A TW200716107 A TW 200716107A TW 095119674 A TW095119674 A TW 095119674A TW 95119674 A TW95119674 A TW 95119674A TW 200716107 A TW200716107 A TW 200716107A
- Authority
- TW
- Taiwan
- Prior art keywords
- methyl
- phenylamino
- benzimidazole
- imino
- pyridin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005025728A DE102005025728A1 (de) | 2005-06-04 | 2005-06-04 | Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200716107A true TW200716107A (en) | 2007-05-01 |
Family
ID=36812978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095119674A TW200716107A (en) | 2005-06-04 | 2006-06-02 | Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
Country Status (22)
Country | Link |
---|---|
US (1) | US20060276513A1 (zh) |
EP (3) | EP2305665A1 (zh) |
JP (1) | JP2008545734A (zh) |
KR (1) | KR20080021763A (zh) |
CN (1) | CN101189224B (zh) |
AR (1) | AR054278A1 (zh) |
AU (1) | AU2006256778A1 (zh) |
BR (1) | BRPI0611099A2 (zh) |
CA (1) | CA2609583A1 (zh) |
DE (1) | DE102005025728A1 (zh) |
EA (1) | EA014082B1 (zh) |
EC (1) | ECSP077981A (zh) |
IL (1) | IL187845A0 (zh) |
MX (1) | MX2007014892A (zh) |
NO (1) | NO20075862L (zh) |
NZ (1) | NZ564621A (zh) |
PE (1) | PE20070082A1 (zh) |
TW (1) | TW200716107A (zh) |
UA (1) | UA92349C2 (zh) |
UY (1) | UY29575A1 (zh) |
WO (1) | WO2006131491A1 (zh) |
ZA (1) | ZA200709715B (zh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
DE102006054005A1 (de) * | 2006-11-16 | 2008-05-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
NZ586868A (en) * | 2008-03-28 | 2012-02-24 | Boehringer Ingelheim Int | Process for preparing orally administered dabigatran formulations |
TWI436994B (zh) * | 2008-07-14 | 2014-05-11 | Boehringer Ingelheim Int | 製備含有達比加群(dabigatran)之藥物組合物的新穎方法 |
TW201022237A (en) | 2008-11-11 | 2010-06-16 | Boehringer Ingelheim Int | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
HUP1000069A2 (en) | 2010-02-02 | 2012-05-02 | Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag | New salts for the preparation of pharmaceutical composition |
WO2011110478A1 (en) | 2010-03-08 | 2011-09-15 | Ratiopharm Gmbh | Dabigatran etexilate-containing pharmaceutical composition |
WO2012027543A1 (en) | 2010-08-25 | 2012-03-01 | Teva Pharmaceuticals Usa, Inc. | Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof |
US9174609B2 (en) | 2011-04-21 | 2015-11-03 | Pylon Manufacturing Corp. | Wiper blade with cover |
HUP1100244A2 (hu) | 2011-05-11 | 2012-11-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Gyógyszeripari intermedierek és eljárás elõállításukra |
JP2014517843A (ja) | 2011-05-24 | 2014-07-24 | テバ ファーマシューティカル インダストリーズ リミティド | 医薬組成物用の圧縮コア |
EP2610251A1 (en) * | 2011-12-29 | 2013-07-03 | Zaklady Farmaceutyczne Polpharma SA | Novel polymorphic forms of dabigatran etexilate and process for the preparation thereof |
US9212166B2 (en) | 2012-01-20 | 2015-12-15 | Cadila Healthcare Limited | Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof |
WO2013124749A1 (en) * | 2012-02-20 | 2013-08-29 | Alembic Pharmaceuticals Limited | Novel polymorph of dabigatran etexilate |
US20130219649A1 (en) | 2012-02-24 | 2013-08-29 | Pylon Manufacturing Corp. | Wiper blade |
EP2872499A1 (en) * | 2012-07-16 | 2015-05-20 | Interquim, S.A. | Process for the preparation of intermediates for the synthesis of dabigatran etexilate, and crystalline forms of said intermediates |
WO2014020546A2 (en) | 2012-07-31 | 2014-02-06 | Ranbaxy Laboratories Limited | Crystalline forms of dabigatran etexilate and process for their preparation |
CA2881947A1 (en) | 2012-08-31 | 2014-03-06 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate |
CN103664881A (zh) * | 2012-09-20 | 2014-03-26 | 天津药物研究院 | 结晶变体形态b的达比加群酯及其制备方法和用途 |
US20150246899A1 (en) | 2012-09-28 | 2015-09-03 | Ranbaxy Laboratories Limited | Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof |
CA2886094A1 (en) | 2012-09-28 | 2014-04-03 | Ranbaxy Laboratories Limited | Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof |
CN103788063B (zh) * | 2012-10-29 | 2016-01-20 | 天津药物研究院 | 四水合达比加群酯晶体及其制备方法和药物用途 |
CN103864756B (zh) * | 2012-12-11 | 2018-06-15 | 四川海思科制药有限公司 | 丁二磺酸达比加群酯及其制备方法和用途 |
WO2014178017A1 (en) | 2013-04-30 | 2014-11-06 | Ranbaxy Laboratories Limited | Dabigatran etexilate impurity, process of its preparation, and its use as a reference standard |
WO2015124764A1 (en) | 2014-02-24 | 2015-08-27 | Erregierre S.P.A. | Synthesis process of dabigatran etexilate mesylate, intermediates of the process and novel polymorph of dabigatran etexilate |
IN2014MU00675A (zh) | 2014-02-26 | 2015-10-23 | Megafine Pharma P Ltd | |
CN104892574A (zh) | 2014-03-04 | 2015-09-09 | 浙江海正药业股份有限公司 | 达比加群酯甲磺酸盐的晶型及其制备方法和用途 |
CN104974137A (zh) * | 2014-04-04 | 2015-10-14 | 江苏天士力帝益药业有限公司 | 达比加群酯甲磺酸盐新晶型及其制备方法 |
WO2017037743A2 (en) * | 2015-09-03 | 2017-03-09 | Sun Pharmaceutical Industries Limited | Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form |
CN105859686B (zh) | 2016-05-24 | 2021-10-08 | 浙江华海药业股份有限公司 | 一种达比加群酯游离碱的精制方法 |
CN106349221A (zh) * | 2016-08-29 | 2017-01-25 | 常州市阳光药业有限公司 | 高纯度达比加群酯的制备方法 |
CN107778291A (zh) * | 2016-08-31 | 2018-03-09 | 亚宝药业集团股份有限公司 | 一种甲磺酸达比加群酯晶型ⅱ的制备方法 |
JP2020193184A (ja) * | 2019-05-30 | 2020-12-03 | ダイト株式会社 | ダビガトランエテキシラートメタンスルホン酸塩の形態iの製造方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675405A (en) * | 1984-09-21 | 1987-06-23 | American Home Products Corporation | Quinoline compounds as antiallergic and antithrombotic agents |
US5416099A (en) * | 1991-10-29 | 1995-05-16 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
PE121699A1 (es) | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
US6414008B1 (en) * | 1997-04-29 | 2002-07-02 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
DK1485094T4 (da) | 2002-03-07 | 2020-06-22 | Boehringer Ingelheim Int | Doseringsform til oral indgivelse af 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester eller dets salte |
DE10235639A1 (de) * | 2002-08-02 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
-
2005
- 2005-06-04 DE DE102005025728A patent/DE102005025728A1/de not_active Withdrawn
-
2006
- 2006-05-31 US US11/421,153 patent/US20060276513A1/en not_active Abandoned
- 2006-06-01 AU AU2006256778A patent/AU2006256778A1/en not_active Abandoned
- 2006-06-01 EP EP10180840A patent/EP2305665A1/de not_active Withdrawn
- 2006-06-01 EP EP06763468A patent/EP1891046A1/de not_active Ceased
- 2006-06-01 BR BRPI0611099-1A patent/BRPI0611099A2/pt not_active IP Right Cessation
- 2006-06-01 KR KR1020087000286A patent/KR20080021763A/ko not_active Application Discontinuation
- 2006-06-01 UA UAA200714329A patent/UA92349C2/ru unknown
- 2006-06-01 EP EP09157302A patent/EP2088146A3/de not_active Withdrawn
- 2006-06-01 NZ NZ564621A patent/NZ564621A/en not_active IP Right Cessation
- 2006-06-01 UY UY29575A patent/UY29575A1/es not_active Application Discontinuation
- 2006-06-01 CA CA002609583A patent/CA2609583A1/en not_active Abandoned
- 2006-06-01 MX MX2007014892A patent/MX2007014892A/es not_active Application Discontinuation
- 2006-06-01 CN CN2006800197579A patent/CN101189224B/zh not_active Expired - Fee Related
- 2006-06-01 EA EA200702541A patent/EA014082B1/ru not_active IP Right Cessation
- 2006-06-01 JP JP2008514111A patent/JP2008545734A/ja active Pending
- 2006-06-01 WO PCT/EP2006/062847 patent/WO2006131491A1/de active Application Filing
- 2006-06-02 TW TW095119674A patent/TW200716107A/zh unknown
- 2006-06-02 PE PE2006000604A patent/PE20070082A1/es not_active Application Discontinuation
- 2006-06-02 AR AR20060102306A patent/AR054278A1/es unknown
-
2007
- 2007-11-12 ZA ZA200709715A patent/ZA200709715B/xx unknown
- 2007-11-15 NO NO20075862A patent/NO20075862L/no not_active Application Discontinuation
- 2007-12-03 IL IL187845A patent/IL187845A0/en unknown
- 2007-12-05 EC EC2007007981A patent/ECSP077981A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL187845A0 (en) | 2008-03-20 |
BRPI0611099A2 (pt) | 2010-08-10 |
EA014082B1 (ru) | 2010-08-30 |
UY29575A1 (es) | 2006-12-29 |
ZA200709715B (en) | 2008-10-29 |
NO20075862L (no) | 2008-02-26 |
US20060276513A1 (en) | 2006-12-07 |
EP2088146A3 (de) | 2009-10-28 |
EA200702541A1 (ru) | 2008-06-30 |
EP1891046A1 (de) | 2008-02-27 |
MX2007014892A (es) | 2008-04-17 |
EP2088146A2 (de) | 2009-08-12 |
UA92349C2 (ru) | 2010-10-25 |
ECSP077981A (es) | 2008-01-23 |
NZ564621A (en) | 2011-03-31 |
AU2006256778A8 (en) | 2008-03-13 |
DE102005025728A1 (de) | 2006-12-07 |
EP2305665A1 (de) | 2011-04-06 |
PE20070082A1 (es) | 2007-01-16 |
KR20080021763A (ko) | 2008-03-07 |
WO2006131491A1 (de) | 2006-12-14 |
CN101189224A (zh) | 2008-05-28 |
CA2609583A1 (en) | 2006-12-14 |
WO2006131491A8 (de) | 2007-12-27 |
AR054278A1 (es) | 2007-06-13 |
CN101189224B (zh) | 2012-03-28 |
AU2006256778A1 (en) | 2006-12-14 |
JP2008545734A (ja) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200716107A (en) | Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | |
WO2008059029A3 (en) | New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate | |
TW200716610A (en) | Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | |
WO2009082152A3 (en) | Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient | |
MY145632A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester-methanesulfonate and its use as a medicament | |
GEP20146166B (en) | Pharmaceutical composition | |
UA102534C2 (en) | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]-dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid | |
WO2007125103A3 (en) | Benzamide glucokinase activators | |
AR072385A2 (es) | Metanosulfonato de ester etilico de acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino]-propionico y composicion farmaceutica para administracion por via oral que lo contiene | |
UA95199C2 (en) | Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
WO2009024611A3 (en) | 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use | |
WO2009156462A3 (en) | Organic compounds | |
TW200609221A (en) | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them | |
TW200745039A (en) | Isotopically substituted pantoprazole | |
WO2007083060A3 (fr) | Derives de chalcone a activite antimitotique | |
TN2012000031A1 (en) | Tablet | |
WO2009060952A1 (ja) | 新規製剤 | |
WO2007129066A8 (en) | 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer | |
WO2007110834A3 (en) | Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | |
WO2010077730A3 (en) | Indanone inhibitors of acetylcholinesterase | |
MY179041A (en) | Crystalline forms of a 3-carboxypropyl-aminotetralin compound | |
WO2010068920A3 (en) | Diaminoquinazoline inhibitors of dihydrofolate reductase | |
ATE546451T1 (de) | Cyclopropancarbonsäureester von acyclovir | |
WO2010061219A3 (en) | Polymorphs | |
WO2008064829A3 (en) | Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof |